FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2904549082> ?p ?o ?g. }

• W2904549082 endingPage "437" @default.
• W2904549082 startingPage "428" @default.
• W2904549082 abstract "Toxoplasmosis causes substantial morbidity and mortality in the United States (US). Clinical manifestations to toxoplasmosis vary and there is limited information on incidence or treatment patterns in the US. Treatment pathways for pyrimethamine-based regimens and trimethoprim-sulfamethoxazole (TMP-SMX) for toxoplasmosis hospitalizations were investigated using the Vizient Health Systems inpatient and outpatient data. Between January 1st, 2011 and December 31st, 2017, 10,273 hospital visits from 4,736 unique patients received a primary or secondary ICD-9/ICD-10 diagnosis for toxoplasmosis. The projected annual hospital visits with a diagnosis of toxoplasmosis was 68,821, corresponding to a total annual incidence of 9,832 comprising ocular toxoplasmosis of 2,169, toxoplasmic encephalitis of 1,399, unspecified toxoplasmosis of 4,368, congenital toxoplasmosis of 381, multisystemic toxoplasmosis of 69 and other toxoplasmosis of 1,446. Only 16.3% of the study population received treatment with pyrimethamine-based regimens or TMP-SMX. Pyrimethamine-based regimens were used significantly more often than TMP-SMX in toxoplasmic encephalitis (88.7% vs 79.6%, p = 0.01), other toxoplasmosis (85.0% vs 79.2%, p = 0.04), and unspecified toxoplasmosis (87.6% vs 77.9%, p = 0.03) in hospitals with 300 beds or more. A significantly higher percentage of visits with TMP-SMX as first-line treatment switched to pyrimethamine-based regimens compared to visits initiated on pyrimethamine-based treatments (26.7% vs 4.1%, p < .001). Ocular toxoplasmosis patients receiving pyrimethamine-based therapy were more likely to be discharged home compared to TMP-SMC at rates of 72.4% and 55.2%, respectively. Our analysis of commercial insurance records suggest toxoplasmosis is undertreated. Overall, pyrimethamine-based regimens are favored over TMP-SMX, have higher rates of discharge home, and have lower switch rates." @default.
• W2904549082 created "2018-12-22" @default.
• W2904549082 creator A5006556422 @default.
• W2904549082 creator A5023835730 @default.
• W2904549082 creator A5031722027 @default.
• W2904549082 creator A5080955758 @default.
• W2904549082 date "2018-11-17" @default.
• W2904549082 modified "2023-09-24" @default.
• W2904549082 title "Patient and treatment pathways for toxoplasmosis in the United States: data analysis of the Vizient Health Systems Data from 2011 to 2017" @default.
• W2904549082 cites W1824605490 @default.
• W2904549082 cites W1943003474 @default.
• W2904549082 cites W1971649732 @default.
• W2904549082 cites W2013549533 @default.
• W2904549082 cites W2065557665 @default.
• W2904549082 cites W2103210761 @default.
• W2904549082 cites W2123719488 @default.
• W2904549082 cites W2128591134 @default.
• W2904549082 cites W2131025240 @default.
• W2904549082 cites W2148629428 @default.
• W2904549082 cites W2153131898 @default.
• W2904549082 cites W2163999998 @default.
• W2904549082 cites W2418871630 @default.
• W2904549082 cites W2464992606 @default.
• W2904549082 cites W2568397404 @default.
• W2904549082 cites W2579545531 @default.
• W2904549082 cites W2580771590 @default.
• W2904549082 cites W2766395728 @default.
• W2904549082 cites W2777706457 @default.
• W2904549082 cites W3022448088 @default.
• W2904549082 cites W4211140781 @default.
• W2904549082 doi "https://doi.org/10.1080/20477724.2018.1552644" @default.
• W2904549082 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6327601" @default.
• W2904549082 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30526421" @default.
• W2904549082 hasPublicationYear "2018" @default.
• W2904549082 type Work @default.
• W2904549082 sameAs 2904549082 @default.
• W2904549082 citedByCount "9" @default.
• W2904549082 countsByYear W29045490822019 @default.
• W2904549082 countsByYear W29045490822020 @default.
• W2904549082 countsByYear W29045490822021 @default.
• W2904549082 countsByYear W29045490822022 @default.
• W2904549082 crossrefType "journal-article" @default.
• W2904549082 hasAuthorship W2904549082A5006556422 @default.
• W2904549082 hasAuthorship W2904549082A5023835730 @default.
• W2904549082 hasAuthorship W2904549082A5031722027 @default.
• W2904549082 hasAuthorship W2904549082A5080955758 @default.
• W2904549082 hasBestOaLocation W29045490821 @default.
• W2904549082 hasConcept C120665830 @default.
• W2904549082 hasConcept C121332964 @default.
• W2904549082 hasConcept C126322002 @default.
• W2904549082 hasConcept C159654299 @default.
• W2904549082 hasConcept C187212893 @default.
• W2904549082 hasConcept C203014093 @default.
• W2904549082 hasConcept C2777035104 @default.
• W2904549082 hasConcept C2778048844 @default.
• W2904549082 hasConcept C2778062946 @default.
• W2904549082 hasConcept C2778128430 @default.
• W2904549082 hasConcept C2778269047 @default.
• W2904549082 hasConcept C2778371730 @default.
• W2904549082 hasConcept C2908647359 @default.
• W2904549082 hasConcept C501593827 @default.
• W2904549082 hasConcept C61511704 @default.
• W2904549082 hasConcept C71924100 @default.
• W2904549082 hasConcept C86803240 @default.
• W2904549082 hasConcept C89423630 @default.
• W2904549082 hasConcept C99454951 @default.
• W2904549082 hasConceptScore W2904549082C120665830 @default.
• W2904549082 hasConceptScore W2904549082C121332964 @default.
• W2904549082 hasConceptScore W2904549082C126322002 @default.
• W2904549082 hasConceptScore W2904549082C159654299 @default.
• W2904549082 hasConceptScore W2904549082C187212893 @default.
• W2904549082 hasConceptScore W2904549082C203014093 @default.
• W2904549082 hasConceptScore W2904549082C2777035104 @default.
• W2904549082 hasConceptScore W2904549082C2778048844 @default.
• W2904549082 hasConceptScore W2904549082C2778062946 @default.
• W2904549082 hasConceptScore W2904549082C2778128430 @default.
• W2904549082 hasConceptScore W2904549082C2778269047 @default.
• W2904549082 hasConceptScore W2904549082C2778371730 @default.
• W2904549082 hasConceptScore W2904549082C2908647359 @default.
• W2904549082 hasConceptScore W2904549082C501593827 @default.
• W2904549082 hasConceptScore W2904549082C61511704 @default.
• W2904549082 hasConceptScore W2904549082C71924100 @default.
• W2904549082 hasConceptScore W2904549082C86803240 @default.
• W2904549082 hasConceptScore W2904549082C89423630 @default.
• W2904549082 hasConceptScore W2904549082C99454951 @default.
• W2904549082 hasIssue "8" @default.
• W2904549082 hasLocation W29045490821 @default.
• W2904549082 hasLocation W29045490822 @default.
• W2904549082 hasLocation W29045490823 @default.
• W2904549082 hasLocation W29045490824 @default.
• W2904549082 hasOpenAccess W2904549082 @default.
• W2904549082 hasPrimaryLocation W29045490821 @default.
• W2904549082 hasRelatedWork W1695430850 @default.
• W2904549082 hasRelatedWork W1976433023 @default.
• W2904549082 hasRelatedWork W2087668195 @default.
• W2904549082 hasRelatedWork W2151871917 @default.
• W2904549082 hasRelatedWork W2293171127 @default.
• W2904549082 hasRelatedWork W2327903814 @default.

• next